Expression of the urokinase plasminogen activator (uPA) receptor (uPAR) has been reported to be elevated at the tumour-stroma border of many cancer types [3–5], including OSCC [6, 7], indicating a role of uPAR in cancer invasion. The gene discussed is PLAUR; the disease is neoplasm.